JP2011184451A5 - - Google Patents

Download PDF

Info

Publication number
JP2011184451A5
JP2011184451A5 JP2011104199A JP2011104199A JP2011184451A5 JP 2011184451 A5 JP2011184451 A5 JP 2011184451A5 JP 2011104199 A JP2011104199 A JP 2011104199A JP 2011104199 A JP2011104199 A JP 2011104199A JP 2011184451 A5 JP2011184451 A5 JP 2011184451A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
azide
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011104199A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011184451A (ja
Filing date
Publication date
Priority claimed from GBGB0316546.1A external-priority patent/GB0316546D0/en
Application filed filed Critical
Publication of JP2011184451A publication Critical patent/JP2011184451A/ja
Publication of JP2011184451A5 publication Critical patent/JP2011184451A5/ja
Pending legal-status Critical Current

Links

JP2011104199A 2003-07-15 2011-05-09 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法 Pending JP2011184451A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0316546.1 2003-07-15
GBGB0316546.1A GB0316546D0 (en) 2003-07-15 2003-07-15 Process for the manufacture of organic compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006519892A Division JP5052132B2 (ja) 2003-07-15 2004-07-15 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法

Publications (2)

Publication Number Publication Date
JP2011184451A JP2011184451A (ja) 2011-09-22
JP2011184451A5 true JP2011184451A5 (enExample) 2013-09-12

Family

ID=27763861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006519892A Expired - Fee Related JP5052132B2 (ja) 2003-07-15 2004-07-15 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法
JP2011104199A Pending JP2011184451A (ja) 2003-07-15 2011-05-09 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006519892A Expired - Fee Related JP5052132B2 (ja) 2003-07-15 2004-07-15 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法

Country Status (34)

Country Link
US (3) US7943647B2 (enExample)
EP (2) EP2116548A1 (enExample)
JP (2) JP5052132B2 (enExample)
KR (5) KR20130140915A (enExample)
CN (1) CN100475823C (enExample)
AR (1) AR045995A1 (enExample)
AT (1) ATE450541T1 (enExample)
AU (1) AU2004263265C1 (enExample)
BR (1) BRPI0412558A (enExample)
CA (1) CA2532175A1 (enExample)
CO (1) CO5670370A2 (enExample)
CY (1) CY1109809T1 (enExample)
DE (1) DE602004024402D1 (enExample)
DK (1) DK1646636T3 (enExample)
EC (2) ECSP066282A (enExample)
ES (1) ES2336333T3 (enExample)
GB (1) GB0316546D0 (enExample)
HR (1) HRP20100088T1 (enExample)
IL (2) IL172946A (enExample)
IS (1) IS8303A (enExample)
MA (1) MA27906A1 (enExample)
MX (1) MXPA06000561A (enExample)
MY (1) MY176840A (enExample)
NO (1) NO20060729L (enExample)
NZ (1) NZ544644A (enExample)
PE (2) PE20050710A1 (enExample)
PL (1) PL1646636T3 (enExample)
PT (1) PT1646636E (enExample)
RU (2) RU2006104322A (enExample)
SI (1) SI1646636T1 (enExample)
TN (1) TNSN06008A1 (enExample)
TW (2) TWI340742B (enExample)
WO (1) WO2005014602A1 (enExample)
ZA (1) ZA200600312B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
JP4537678B2 (ja) * 2003-09-04 2010-09-01 住友化学株式会社 2’−(1h−テトラゾール−5−イル)ビフェニル−4−カルボアルデヒド結晶およびその製造方法
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
GB0514206D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
GB0514686D0 (en) * 2005-07-18 2005-08-24 Novartis Ag Organic compounds
WO2007020654A1 (en) * 2005-08-16 2007-02-22 Suven Life Sciences An improved process for the preparation of losartan
WO2007026375A1 (en) * 2005-08-31 2007-03-08 Suven Life Sciences Process for the preparation of losartan
KR100795589B1 (ko) * 2006-05-29 2008-01-21 주식회사 대희화학 2-부틸-4-클로로-1-[[2'-(1h-테트라졸-5-일)바이페닐-4-일]메틸]이미다졸-5-카르복스알데하이드의 제조방법
CN101200455B (zh) * 2007-09-29 2010-08-18 泰兴市江神化工有限公司 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法
US7932279B2 (en) 2007-10-12 2011-04-26 Arqule, Inc. Substituted tetrazole compounds and uses thereof
EP2316821A1 (en) * 2009-10-27 2011-05-04 Novartis AG Process for the manufacture of organic compounds
US8530506B2 (en) 2009-11-17 2013-09-10 Mitsubishi Tanabe Pharma Corporation Process for production of biphenyl derivative
US10368340B2 (en) * 2010-04-01 2019-07-30 Hon Hai Precision Industry Co., Ltd. Network service exposure method and apparatus utilizing the same
WO2012148148A2 (en) * 2011-04-25 2012-11-01 Lg Life Sciences Ltd. Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
CN102351804B (zh) * 2011-09-30 2013-07-31 浙江新赛科药业有限公司 一种缬沙坦消旋体的回收方法
CN102702117B (zh) * 2012-06-01 2016-04-13 浙江沙星医药化工有限公司 一种制备5-(4’-溴代甲基-2-联苯基)-1-三苯甲基四氮唑的方法
CN103265560B (zh) * 2013-05-17 2016-05-04 中国科学院上海高等研究院 棉酚/棉酮衍生物及其制备方法和抗肿瘤药物中的应用
KR101956281B1 (ko) * 2013-08-13 2019-03-08 삼성전기주식회사 수지 조성물, 이를 이용한 인쇄회로기판 및 그 제조방법
KR102090155B1 (ko) * 2019-11-22 2020-03-17 국방과학연구소 베타인 수용액 내에서 5-치환-1h-테트라졸의 제조방법
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
CN116375687A (zh) * 2021-12-22 2023-07-04 浙江华海药业股份有限公司 一种高纯度的氯沙坦钾及其制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977372A (en) * 1958-04-09 1961-03-28 William G Finnegan Process for preparing substituted tetrazoles
US3394142A (en) * 1966-01-19 1968-07-23 Minnesota Mining & Mfg Substituted tetrazoles and process therefor
CH499526A (de) 1968-06-06 1970-11-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Tetrazolderivaten
SU497775A3 (ru) 1970-01-16 1975-12-30 Циба-Гейги Аг (Фирма) Способ получени производных тетразола
DE2650231A1 (de) * 1976-11-02 1978-05-11 Hoechst Ag Neue imidazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4097479A (en) * 1977-03-11 1978-06-27 Miles Laboratories, Inc. Synthesis of 5-substituted tetrazoles
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4288352A (en) 1979-03-26 1981-09-08 Exxon Research & Engineering Co. Electrically conductive polymeric compositions
FI73423C (fi) * 1980-02-29 1987-10-09 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av farmakologiskt verksamma tetrazolderivat.
JPS56158781A (en) 1980-05-10 1981-12-07 Kaken Pharmaceut Co Ltd Tetrazolecoumarin derivative, its preparation and antiallergic agent containing the same as active constitutent
US4338452A (en) * 1980-09-17 1982-07-06 Eli Lilly And Company 1-and 2-(1-Alkyl-1H-tetrazol-5-yl-methyl)-1H-tetrazol-5-thiols and 1-cyanomethyl tetrazole-5-thiol
US4735948A (en) 1983-03-25 1988-04-05 Merrell Dow Pharmaceuticals Inc. (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
JPS6073028A (ja) 1983-09-29 1985-04-25 Japan Electronic Control Syst Co Ltd 電子制御燃料噴射式内燃機関の始動時の噴射量の学習制御装置
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB8708459D0 (en) 1987-04-09 1987-05-13 Avdel Ltd Fastener installation apparatus
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4870186A (en) * 1987-05-22 1989-09-26 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4874867A (en) * 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5210079A (en) * 1988-01-07 1993-05-11 E. I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
US5128069A (en) * 1989-03-22 1992-07-07 Nippon Zoki Pharmaceutical Co., Ltd. Luciferin derivatives
DE122010000024I1 (de) 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
PT97078B (pt) 1990-03-20 1997-07-31 Sanofi Sa Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
US5284954A (en) 1990-09-10 1994-02-08 Abbott Laboratories Process for the preparation of tetrazoles
AU9137791A (en) 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5602127A (en) * 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
US5594003A (en) * 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
JP2524842Y2 (ja) 1991-02-28 1997-02-05 三菱重工業株式会社 原紙供給装置
US5447949A (en) * 1991-05-15 1995-09-05 Smithkline Beecham Corporation N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
WO1993004046A1 (en) 1991-08-19 1993-03-04 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
DK0600950T3 (da) 1991-08-22 1997-04-21 Warner Lambert Co Tetrazolamider som inhibitorer af ACAT
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
IL104406A0 (en) 1992-01-17 1993-05-13 Syntex Inc Substituted 1-isoquinolone derivatives,their preparation and pharmaceutical compositions containing them
DE4203872A1 (de) * 1992-02-11 1993-08-12 Thomae Gmbh Dr K Imidazo(1,2-a)pyridine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4206045A1 (de) * 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl substituierte pyridone
US5484955A (en) 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
JP2990566B2 (ja) * 1992-07-06 1999-12-13 武田薬品工業株式会社 トリ高級アルキルスズアジドおよびその用途
JPH06107658A (ja) 1992-09-28 1994-04-19 Kanebo Ltd 新規なピラジン誘導体
US5256658A (en) * 1993-01-15 1993-10-26 Ortho Pharmaceutical Corporation Angiotensin II inhibitors
US5502191A (en) * 1993-07-01 1996-03-26 American Cyanamid Company Method of synthesizing sterically hindered 5-substituted-1H-tetrazoles from nitriles using a lewis acid and an azide
JPH09507075A (ja) * 1993-12-23 1997-07-15 メルク エンド カンパニー インコーポレーテッド ロサルタンの多形とロサルタン▲ii▼形調製のための方法
JPH09510968A (ja) 1994-03-25 1997-11-04 メリル.フアーマシユウテイカルズ・インコーポレイテツド (1H−テトラゾル−5−イル)テトラゾロ〔1,5−a〕キノリン類およびナフチリジン類の製造方法
CA2186513C (en) 1994-03-28 1999-03-16 James F. Eggler Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
US5541209A (en) 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
JPH08325248A (ja) 1995-05-26 1996-12-10 Chugoku Kayaku Kk テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
JP3671266B2 (ja) 1996-03-21 2005-07-13 東洋化成工業株式会社 5−置換テトラゾール類の製造方法
JPH10218868A (ja) 1997-02-12 1998-08-18 Toyo Kasei Kogyo Co Ltd 5ーメチルテトラゾールの製造方法
JP4450881B2 (ja) 1998-12-28 2010-04-14 株式会社日本ファインケム 5,5’−ビ−1h−テトラゾール塩の製造方法
JP2000281662A (ja) 1999-03-31 2000-10-10 Masuda Kagaku Kogyo Kk テトラゾール類の製造方法
DE19935219A1 (de) * 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
CA2385568A1 (en) * 1999-09-27 2001-04-05 The Dow Chemical Company Supported catalyst comprising expanded anions
US20040072886A1 (en) * 2002-04-15 2004-04-15 Dr. Reddy's Laboratories Limited Novel crystalline forms of (S)-N- (1-Carboxy-2-methyl-prop-1-yl) -N-pentanoyl-N- [2' -(1H-tetrazol-5-yl)- biphenyl-4-yl methyl] amine (Valsartan)
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
US6934312B2 (en) * 2002-09-30 2005-08-23 Agilent Technologies, Inc. System and method for fabricating efficient semiconductor lasers via use of precursors having a direct bond between a group III atom and a nitrogen atom
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
EP1660463B1 (en) * 2003-08-08 2007-12-05 Dipharma Francis S.r.l. A process for the preparation of phenyltetrazole derivatives
BRPI0508164A (pt) 2004-03-17 2007-08-07 Kennecott Utah Copper Corp aparelho e método para monitorar uma célular eletrolìtica

Similar Documents

Publication Publication Date Title
JP2011184451A5 (enExample)
US10584109B2 (en) Processes for preparing antiviral compounds
JP2009513555A5 (enExample)
Zhou et al. Ni-catalyzed migratory fluoro-alkenylation of unactivated alkyl bromides with gem-difluoroalkenes
CA2826260C (en) Methods of making hiv attachment inhibitor prodrug compound and intermediates
JP2010037289A (ja) 3官能ニトリルオキシドおよびその製造方法
EP3377475A1 (en) 4-((6-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
WO2013108024A1 (en) Aromatic compounds and methods of making the same
CN100406443C (zh) 用于制备喹诺酮抗生素中间体的方法
CN106573874B (zh) 制造2-氨基取代苯甲醛化合物的方法
WO2009155403A2 (en) Processes for the preparation of varenicline and intermediates thereof
TW201139389A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles
CN110483549A (zh) 一种硝基咪唑吡喃类抗结核药物的制备方法
AU2019213854C1 (en) Pyrazole compounds and preparation thereof
JP2017218460A (ja) 放射ヨウ素標識された3−フルオロプロピル−NOR−β−CITの調製
TW200304438A (en) Sulfurpentafluoride compounds and methods for making and using same
JP6868890B2 (ja) 環上に置換基を有する含窒素環状化合物の製造方法
JP7315805B1 (ja) 単環ピリジン誘導体の合成中間体の製造方法
JP2016508512A (ja) ビス−ジハロアルキルピラゾールの製造方法
US10214480B2 (en) Synthesis process for chiral cyclopropyl ethynyl tertiary alcohol compound
JP2022035954A (ja) N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
CN112778224B (zh) 一种合成更昔洛韦类似物的方法
TWI361807B (en) Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes
EA050475B1 (ru) Способ синтеза производных нафтиридина и их промежуточных соединений
TW202419441A (zh) 烷基矽烷氧取代苄胺化合物之製造方法